Skip to search formSkip to main contentSkip to account menu

CGP 12177

Known as: 2H-Benzimidazol-2-one, 4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-, CGP-12177 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Agonist-stimulated desensitization of the beta2-adrenergic receptor (beta2AR) is caused by both a potent cAMP-dependent protein… 
Highly Cited
1993
Highly Cited
1993
BACKGROUND Positron emission tomography (PET) with 11C-labeled CGP-12177 (CGP) has been shown to have the potential to… 
1993
1993
  • M. Law
  • British journal of pharmacology
  • 1993
  • Corpus ID: 24814025
1 Positron emission tomography (PET) with appropriate radioligands offers the possibility of studying receptors non‐invasively in… 
Highly Cited
1992
Highly Cited
1992
  • S. Liggett
  • Molecular Pharmacology
  • 1992
  • Corpus ID: 43830428
beta 3-Adrenergic receptors (beta 3AR) mediate lipolytic and thermogenic responses in rodent adipose tissues in vitro, and… 
Highly Cited
1992
Highly Cited
1992
The presence of a beta-3 adrenoceptor (in addition to the classical beta-1 and beta-2 adrenoceptors) and its involvement in the… 
Highly Cited
1991
Highly Cited
1991
The in vivo quantification of myocardial beta-adrenergic receptor has been obtained in five closed-chest dogs using positron… 
Highly Cited
1989
Highly Cited
1989
The effect of CGP-12177, originally developed as a radioligand with antagonist properties for binding studies of beta-adrenergic… 
Highly Cited
1983
Highly Cited
1983
Isoprenaline treatment of C6-glioma cells induced a fast decrease in the number of beta-adrenergic receptors as determined by…